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Abstract
The proprotein convertases (PCs) furin and PACE4 process numerous substrates involved in tumor growth, invasion,
and metastasis. We have previously shown that PCs increase the susceptibility to chemical skin carcinogenesis.
Because of the human relevancy of UV radiation in the etiopathogenesis of human skin cancer, we investigated
whether or not transgenic mice overexpressing either furin alone or both furin and PACE4 show increased suscepti-
bility to UV carcinogenesis. After backcrossing our previously described furin and PACE4 transgenic lines, targeted
to the epidermis, into a SKH-1 background, we exposed both single and double transgenic mice to UV radiation
for 34 weeks. The results showed an increase in squamous cell carcinoma (SCC) multiplicity of approximately 70%
in the single furin transgenic mouse line SF47 (P < .002) and a 30% increase in the other single transgenic line
SF49 when compared to wild-type (WT) SKH-1 mice. Interestingly, there was also an increase in the percentage
of high histologic grade SCCs in the transgenic lines compared to the WT mice, i.e., WT = 9%, SF47 = 15%, and
SF49 = 26% (P < .02). Targeting both furin and PACE4 to the epidermis in double transgenic mice did not have
an additive effect on tumor incidence/multiplicity but did enhance the tumor histopathologic grade, i.e., a significant
increase in higher grade SCCs was seen in the bigenic mouse line SPF47 (P < .02). Thus, we observed an increased
susceptibility to UV in single furin transgenic mice that was not substantially enhanced in the double furin/PACE4
transgenic mice.
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Introduction
Skin carcinogenesis has been studied for almost a century based on
very early observations made on chimney sweeps and by later experi-
mentation using coal tar [1]. The use of carcinogenic and cocarcino-
genic chemicals lead to the discovery of multiple steps during the
process of skin carcinogenesis defined as tumor initiation, tumor pro-
motion, and tumor progression. These operationally defined steps of
carcinogenesis have resulted from the use of the two-stage carcino-
genesis model or protocol that employs a subcarcinogenic dose of a
polycyclic hydrocarbon followed by numerous topical applications of
a hyperplasiogenic non-carcinogenic agent, usually a phorbol ester
[2–4]. The experiments using this model have been very popular in
the last half of the 20th century and resulted in numerous advances in
our knowledge of skin carcinogenesis and of carcinogenesis in general.
Abbreviations: IHC, immunohistochemistry; PCs, proprotein convertases; SCCs,
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The model of two-stage carcinogenesis is considered a paradigm for
the process of human cancer development permitting the dissection
of the carcinogenesis process that is applicable to most cancer sites.
Nevertheless, when we focus on the etiology of human skin cancer,
including non-melanoma cancers, solar UV radiation is the main
cause of skin cancer. There is overwhelming evidence that exposure
to UV radiation is the principal cause of DNA damage and other
molecular events and that UV acts as a complete carcinogen with both
initiating and promoting properties [5].
Proprotein convertases (PCs) are a group of serine proteinases
implicated in regulating numerous physiological and pathologic pro-
cesses [6–8] by proteolytic activation of precursor proteins. The fol-
lowing PCs have been identified so far: PC1/3, PC2, furin, PC4,
PC5/6, PACE4, PC7, SKI-1/S1P, and PCSK9 [8–11]. Most of
these enzymes exert their functions by activating precursor protein
substrates, cleaving them at basic residues within the motif (K/R)-
(X)n-(K/R). Many PC protein substrates are growth factors and
their cognate receptors, as well as metalloproteinases and adhesion
molecules. These substrates have considerable influence on the
development of the neoplastic cell phenotype [12–24]. Numerous
studies have highlighted the role of PC1, PC2, furin, PC5, PACE4,
and PC7 in regulating the biologic behavior of tumors [25–30].
Many focused on furin, a ubiquitously expressed type I membrane-
bound proteinase, e.g., our laboratory has reported that this PC
is implicated in human squamous epithelial cancer cells of different
origins [31–34].
Our laboratory and others determined their significant participa-
tion in cutaneous and non-cutaneous tumor development and growth
[33–41]. In previous reports, we observed that transgenic expression
of either furin or PACE4 in keratinocytes of the epidermal basal layer
was more susceptible to chemical carcinogenesis [42,43], evidenced
by increased tumor multiplicity, tumor volume, and metastasis.
Moreover, inhibition of PCs in this model resulted in decreased cell
proliferation and reduced tumor multiplicity and volume, effectively
reducing tumor burden [44].
Motivated by the fact that UV exposure of human immortalized
keratinocytes is able to induce the expression of one of the most studied
PCs, namely, furin [45], and that UV is the principal human skin car-
cinogen, we decided to evaluate whether furin overexpression would
increase the susceptibility of transgenic mice in which the furin transgene
is targeted to the epidermis. Moreover, to investigate possible additive
or synergistic effects between furin and PACE4, we developed double
transgenic mice expressing both PCs targeted to the epidermis.
Materials and Methods
Animals and UV Treatment
Transgenic mice overexpressing furin, under the control of the
bovine keratin 5 (K5) promoter, were designed and developed in an
FVB background as described in a previous report [43]. Two K5-furin
mouse lines (F47 and F49) were backcrossed for at least six genera-
tions to wild-type (WT) SKH-1 hairless mice obtained from Charles
River Laboratories (Wilmington, MA) for transmission of the trans-
gene and hairlessness. Mice were genotyped by polymerase chain
reaction (PCR) analysis of tail DNA using primers specific for an
internal fragment of human furin and the junction of furin with SV40
polyadenylation signal. The sequence of sense primer was 5′GTGC-
TGTCTCATCGATTTGGCAA3′ and that of antisense primer was
5′GCGGGCGGTGAGGCGACA3′. After obtaining the backcrossed
K5-furin transgenic mouse lines (now called SF47 and SF49), we also
obtained by the same backcrossing procedures a K5-PACE4 line on
SKH-1 background that was derived from a previously developedmouse
line originally in an FVB background [42]. This line, now called
SPACE4, was crossed with either SF47 or SF49 to obtain double trans-
genicmouse lines (SPF47 and SPF49).Table 1 summarizes the genotype
of the mice used in this report.
All mice of SKH-1 background were housed in the Laboratory
Animal Facility at Fox Chase Cancer Center according to the require-
ments established by the American Association for Accreditation of
Laboratory Animal Care.
Mice were exposed dorsally to gradually increasing doses of ultra-
violet B (UVB; starting with a dose of 0.25 kJ/m2 and increasing every
3 weeks by multiples of 0.25 kJ/m2 to reach the full dose of 1 kJ/m2).
Philips TS40UVB lamps (American Ultraviolet Company, Murray Hill,
NJ), fitted with Kodacel filters (Eastman Kodak, Rochester, NY), were
used to deliver emissions in the UVB range of 290 to 320 nm [46].
The animals were irradiated two times weekly for 34 weeks. The mice
were placed on a shelf 20 cm below the light tubes for irradiation.
The cage order was rotated before each treatment to compensate for
uneven lamp output [47,48]. UV radiation dosage was measured using
a UVX radiometer (UVX-31) from UVP (Upland, CA).
RNA Extraction and Real-Time PCR
RNA was extracted using the RNAqueous Kit from Ambion, Inc
(Austin, TX). Contaminating DNA from RNA preparations was
removed using TURBO DNA-free (Ambion, Inc), and the purified
RNA was quantified with Agilent 2100 Bioanalyzer in combination
with RNA 6000 Nano LabCHip. One hundred twenty nanograms of
RNA was reversely transcribed using the M-MLV reverse transcriptase
(Ambion, Inc) and a mixture of anchored oligodT and random deca-
mers. Real-time PCR assays for PCs were performed as described previ-
ously using similar primers [43] using an ABI 7900 HT instrument.
Tumor Induction and Histopathology
Tumor incidence and multiplicity were observed weekly. The type
and number of mice per group in the first experiment involving sin-
gle transgenic mice were given as follows: WT SKH-1 (n = 18), sin-
gle furin transgenic line SF47 (n = 19), and single furin transgenic
line SF49 (n = 19). In the double transgenic carcinogenesis experi-
ment, we used the following animal groups: WT SKH-1 (n = 20),
single transgenic K5 PACE4 [42] backcrossed to SKH-1 back-
ground, herein referred to as SPACE4 (n = 23), double transgenic
SPF47 (n = 17), and double transgenic SPF49 (n = 19). Papillomas
Table 1. Nomenclature of Mouse Lines Used in the Short-Term and Carcinogenesis Experiments.
Mouse Line Furin Transgene PACE4 Transgene
WT (SKH-1) − −
SF47 + −
SF49 + −
SPACE4 − +
SPF47 + +
SPF49 + +
Note that all transgenic mouse lines have been backcrossed to an SKH-1 background.
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and squamous cell carcinomas (SCCs) were recorded by gross obser-
vation twice weekly and confirmed by histologic analysis at 34 weeks.
Autopsies of carcinoma-bearing mice were performed, and metastasis
in axial lymph nodes, lung, liver, spleen, and other organs were re-
corded. All tumors were analyzed histologically. SCCs were classified
according to histopathologic grade [49]. Most SCCs were endophytic
growths that invaded the dermis and subcutaneous tissue. The differ-
entiation patterns defining the histopathologic grade were given as fol-
lows: 1) grade I SCC, very well differentiated with most of the tumors
containing keratinizing cells and horny pearls; 2) grade II SCC, mod-
erately differentiated tumors in which up to 50% of the tumor mass
is formed by keratinizing cells; 3) grade III SCC, poorly differentiated
tumors, containing less than 25% tumor mass showing evidence of
keratinization; and 4) grade IV SCCs, very poorly differentiated tumors
or spindle cell carcinomas, containing very little or no histologic evidence
of keratinization.
Keratinocyte Cultures and Western Blot Analyses
Primary epidermal keratinocytes from newborn mice were used to
determine expression levels of furin because of their suitability for
in vitro growth and further molecular analyses. Primary epidermal
keratinocytes were established in vitro as described [50,51]. Briefly,
1- to 3-day-old mice were killed; the skin was washed in a 1:10 solution
of Betadine and rinsed twice in sterile dH2O and twice in 70% alcohol.
The skin was removed and floated overnight on 2 ml of dispase
(Dispase II, 25 U/ml; BD Biosciences, Bedford, MA). The epidermis
was separated from the dermis, minced, and incubated with 2 ml of
0.05% trypsin and 0.01% EDTA for 20 minutes at 37°C. DNase I
(100 units) was added, and the cells were mechanically dissociated
by vigorous pipetting followed by filtration through a 40-μm cell
strainer (BD Biosciences). The cells were washed in Dulbecco’s modi-
fied Eagle’s medium containing 10% fetal calf serum and plated in a
1:2 mixture of keratinocyte growth medium (KGM) with Ca2+ (catalog
number 3101; Cambrex, Waskerville, MD) and Ca2+-free KGM
(catalog number 104; Cambrex) plus 4 ml of KGM supplements and
growth factors (SingleQuot Kit, catalog number 4131; Cambrex) per
500 ml medium.
The keratinocytes grown in culture dishes were lysed and sub-
jected to furin Western blot analysis according to our previously re-
ported protocol [52]. A monoclonal antibody against human furin
that recognizes the transgenic protein but not the endogenous furin
(MON-152, ALX-803-017; ALEXIS, Plymouth Meeting, PA) was
used as the primary antibody.
The processing of insulin-like growth factor-1 receptor (IGF-1R) in
keratinocytes was performed by culturing keratinocytes to 80% to
90% confluency and subsequently treating cells with furin convertase
inhibitor, decanoyl-RVKR-chloromethylketone (CMK, ALX-260-022;
Enzo Life Sciences, Plymouth Meeting, PA), at different concentrations.
Twenty-four hours after CMK treatment, the keratinocytes were lysed
and subjected toWestern blot analysis with a polyclonal antibody against
IGF-1Rβ (C-20, sc-713; Santa Cruz Biotechnology, Santa Cruz, CA).
The quantification of Western blot results was performed by using ImageJ
developed by the National Institutes of Health.
Primary epidermal keratinocytes from WT and transgenic SKH-1
mice were grown in chamber slides and either sham exposed (0 kJ) or
exposed to 0.5 and 1 kJ of UVB as described above to evaluate the
acute effect of UV irradiation. Immunohistochemistry (IHC) of
furin was evaluated 15 minutes, 5 hours, and 24 hours after irradi-
ation using the IHC technique described below.
Analysis of Epidermal Thickness and Cell Proliferation
Following UV Exposure
To evaluate whether furin expression alters the histology and pro-
liferative ability of the epidermis, we compared the proliferative
response to an acute exposure of UV radiation. Following the same
exposure conditions as described above, we subjected the dorsal skin
to UV exposure twice weekly (1.00 kJ/m2) for 2 weeks. Groups of
WT or furin transgenic mice (n = 5 per group) were treated, and
groups of untreated mice of the same characteristics were used
as controls. All mice were killed 48 hours after the last treatment.
Paraffin sections were obtained and stained with hematoxylin and
eosin, and epidermal thickness was measured with the aid of a mor-
phometry software that permits length measurements using digital
imaging (Image Pro-Plus; Media Cybernetics, Silver Spring, MD).
For analysis of cell proliferation, paraffin sections were used for
detecting the proliferation marker Ki67, using a rat monoclonal
antibody (clone TEC-3; Dako, Carpinteria, CA) and a biotinylated
goat anti-rat IgG antibody (mouse adsorbed) together with an ABC
Detection Kit (Vector Elite; Vector, Burlingame, CA). Slides were
mounted and observed with a Nikon Optiphot with a Plan/Apo
objective of ×20, NA of 0.75, Nikon eyepiece of ×10, and a final
magnification of ×200. Epidermal cell proliferation index was deter-
mined in the interfollicular epidermis by scanning the slides using an
Aperio CS Scanscope scanner (Aperio, Vista, CA) and counting
Ki67-positive and Ki67-negative epidermal basal keratinocytes and
determining the percentage of positive cells (three to fivemice per group;
minimal number of cells counted per mouse was 500 per mouse).
IHC of Furin
Furin IHC was performed using paraffin-embedded normal skin,
normal internal organs, and cutaneous tumors from WT and trans-
genic mice. All paraffin sections were subjected to a previously pub-
lished immunostaining protocol [49,53]. A monoclonal antibody
Figure 1. Furin transgenic mice. (A) PCR from DNA extracted from
mouse tails, showing WT and two transgenic animal lines (SF47
and SF49). (B) Western blot showing expression of human furin
protein in cultured epidermal cells from transgenic lines.
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against furin (MON-148, ALX-803-015; ALEXIS) was employed as
primary antibody at a dilution of 1:200. Furin-positive cells were
counted in the interfollicular epidermis and expressed as furin-
positive cells per mm of epidermal basement membrane (BM).
BM length was determined in furin-stained skin sections and the
furin-positive cells of the respective interfollicular epidermal sector
was counted using the above-mentioned morphometry software
that permits length measurements of digitalized images. BM length
was determined in control and UV-treated epidermis (three to five
mice per group, minimal BM length per mouse was 2 mm per sec-
tion). In addition, furin IHC intensity was evaluated in primary
keratinocyte cultures counterstained with hematoxylin, which were
then scanned with the Aperio ScanScope CS scanner using the
Positive Pixel Count V9 algorithm and the ImageScope software
built into the scanner. UV-irradiated and control cells were evaluated
(n = 223 cells).
Statistical Analysis
Both two-sample t test and Wilcoxon test were used to compare
tumor incidence and tumor volume. Wilcoxon test, a non-parametric
test, was used when sample size was small. T test was used when the
sample size in each comparison group was greater than 30. A P value
Figure 2. Immunohistochemistry of furin in dorsal mouse epidermis. Panels A (WT SKH-1), C (F47), and E (F49) depict control un-
irradiated epidermis. Panels B (WT), D (SF47), and F (SF49) show UV-irradiated epidermis. Both the unirradiated (A) and irradiated
WT epidermis (B) show negative or marginal immunostain. Panel C (SF47) exhibits several furin-positive basal keratinocytes that further
increased together with occasional positive parabasal keratinocytes after UV irradiation (D). Epidermis from SF49 (E) shows increased
expression of furin in basal keratinocytes after UV exposure (F). Furin IHC and hematoxylin counterstain × 150. The histogram (G) shows
an increase in the number of positive basal keratinocytes in transgenic epidermis. Asterisks indicate significantly different changes
when compared with the respective WT (P < .001).
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of less than .05 was considered statistically significant. All statistical
analyses were performed using SAS 9.2.
Results
Characterization of Transgenic Mice
After backcrossing for six generations two K5-furin lines, originally
developed in FVB background [43], to SKH-1 background, their
transgenic nature was detected by PCR analysis. The two transgenic
lines called SF47 and SF49 were genotyped by PCR of genomic
DNA using primers amplifying a DNA segment between 300 and
400 bp, and a representative genotyping experiment is shown in
Figure 1A. Transgene expression was confirmed by Western blot
analysis of furin protein expression. Furin protein was clearly expressed
in the keratinocytes from both transgenic mouse lines (molecular
weight, ∼100 kDa). WT keratinocytes showed no transgenic furin
expression (Figure 1B ). Densitometric evaluation of four different
Western blots demonstrated that line SF49-derived epidermal keratino-
cytes expressed approximately twice as much furin as line SF47-derived
keratinocytes (ratio SF49/SF47 = 2.5). Double transgenics and
SPACE4 mice were similarly characterized for PACE4; for genotyping,
we used primers and procedures previously developed [42].
Furin Expression in the Epidermis and Other Epithelia
The distribution of furin expression in transgenic mice was further
analyzed by IHC staining. In WT mice, furin expression was prac-
tically absent, although occasionally it could be observed as minimal
punctuate staining in the perinuclear cytoplasm of basal epithelial
cells in the epidermis. Conversely, furin was clearly detected by
IHC in most squamous epithelia of transgenic mice, including tail
epidermis, oral mucosa, genital mucosa, and biliary ducts as has been
previously seen in similar transgenics of FVB background [43] (data not
shown). The location of furin was cytoplasmic, predominately over-
expressed in the epidermal basal layer, mostly undetectable inWTmice
(Figure 2A), but clearly observed in both transgenic lines (Figure 2, C
and E ). Neither gross nor histologic phenotypic alterations were
observed by the expression of furin in transgenic mouse lines.
We examined the processing of IGF-1R, one of the most biolog-
ically relevant substrates of furin, in mouse-derived epidermal primary
Figure 3. Western blot analysis of IGF-1R processing in WT and transgenic primary keratinocyte cultures (A). The cells were challenged
in vitrowith different doses of the PC inhibitor CMK to investigate the sensitivity of primary keratinocytes to IGF-1R cleavage inhibition by
CMK; 3 μM CMK, and more clearly after 12.5 μM CMK, was able to inhibit PC-mediated IGF-1R processing in WT keratinocytes. The
effect was noted by the presence of IGF-1R precursor or proform with increasing concentrations of CMK. Conversely, the CMK treat-
ment failed to increase significantly the levels of the IGF-1R precursor in SF47- and SF49-derived cells. Panel B shows these changes as
depicted by plotting the ratios of densitometric evaluations of IGF-1R precursor to processed bands.
Figure 4. Quantitative RT-PCR of PCs using mouse normal kera-
tinocytes in short-term culture. All PC transcript expression values
(y axis) are expressed as ratios between the respective PC and
actin control expression. Note that the expression level of furin is
increased at 24 hours (1 day) after UVB exposure in SF47 transgenic–
derived keratinocytes but not at the other time points (0 kJ or
untreated, 15 minutes and 5 hours). PCs detected were the endo-
genous mouse proprotein convertases furin (fur), PACE4, and PC7.
Neoplasia Vol. 15, No. 2, 2013 UV Carcinogenesis in Furin Transgenic Mice Fu et al. 173
keratinocyte cultures. Interestingly, the difference of IGF-1R proces-
sing in keratinocytes derived from WT SKH-1 mice and SF47 and
SF49 transgenic mice of the same background was marginal, suggesting
that the endogenous furin expressed in WT keratinocytes efficiently
processed pro–IGF-1R. To observe a difference in the activating ability
of transgenic and WT-derived keratinocytes, we challenged the cells
in vitro with different doses of the PC inhibitor CMK to investigate
the sensitivity of primary keratinocytes to IGF-1R cleavage inhibition
by CMK. As shown in Figure 3, a dose as low as 3 μMCMK was able
to inhibit PC-mediated IGF-1R processing in WT keratinocytes, and
the inhibitory effect was directly proportional to the CMK dose up to a
maximal effect at a dose of 100 μM. The effect was noted by the
increasing presence of the IGF-1R proform with increasing concen-
trations of CMK (Figure 3). Conversely, the CMK treatment, even
at the highest dose, failed to increase the levels of the IGF-1R pro-
form in SF47- and SF49-derived cells, suggesting that the high level
of furin expression in transgenic keratinocytes overcomes the inhibitor
and that the PC is able to activate the IGF-1R substrate, leaving little
proform behind.
Short-Term In Vitro Experiments
Since a previous report showed that UV exposure of human
immortalized keratinocytes can induce up-regulation of furin [45],
we exposed WT and transgenic-derived epidermal keratinocytes to
UVB radiation. Contrary to the published data, WT mouse cultured
keratinocytes showed no or marginal increase in three PCs at most
Figure 5. Furin expression in murine epidermal keratinocytes in primary culture detected with IHC. Panels A, B, and C correspond to
unirradiated cultures derived fromWT SKH-1, SF47, and SF49 mice, respectively. Similarly A′, B′, and C′ correspond to UVB-irradiated WT
(SKH-1)–, SF47-, and SF49-derived cultured keratinocytes. The cells were irradiated with 0.5 kJ as described in the text and evaluated
15 minutes post-exposure. Furin IHC and hematoxylin counterstain × 1000. Panel D shows image analysis values of furin positivity in the
cytoplasm using a quantification procedure based on computerized image analysis as described in the Materials and Methods section.
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time points studied (furin, PACE4, and PC7). Nevertheless, we
found a slight increase in furin RNA 24 hours post-irradiation in
keratinocytes derived from WT and SF47 mice (but not in SF49-
derived cells, data not shown). Although, at the RNA level, transgenic
keratinocytes showed a mild increase in furin transcript expression
compared with their WT counterparts (Figure 4), when investigated
at the protein level by quantitative image analysis of furin IHC, we ob-
served a statistically significant increase in furin expression in keratino-
cytes derived from the SF47 mouse line after UV exposure when
compared to UV-exposed WT keratinocytes (P < .01; Figure 5).
Short-Term In Vivo Experiments
To evaluate differences in epidermal proliferation between WT
and transgenic mice, we exposed the skin to two doses of UVB irra-
diation (0.5 kJ/m2 each, separated by 48 hours) and analyzed furin
expression levels, epidermal thickness, and Ki67 index, 48 hours after
the last UV administration. When comparing untreated WT, SF47,
and SF49 epidermis, it was obvious that the number of strongly expres-
sing furin basal epidermal keratinocytes was higher in SF47 and SF49
mouse epidermis than in WT epidermis (P < .001; Figure 2, A–G ).
Both SF47 and SF49 epidermis showed an increase in the number of
furin-expressing keratinocytes after UV irradiation. This expression was
similar in both transgenic mouse lines. Furin-expressing basal keratino-
cytes in SF47 and SF49 mouse epidermis was significantly enhanced
with respect toWT following short-term UVB exposure (P < .001; Fig-
ure 2, B, D, and F ). As expected, UV exposure increased keratinocyte
proliferation as expressed by the variation in epidermal thickness and
the number of positively stained nuclei using Ki-67 IHC in the skin
samples from all groups (data not shown). This increment was approx-
imately two-fold to three-fold when comparing epidermal thickness
increase before and after irradiation in all groups but was more pro-
nounced in SF47 mice (P < .01). Although the proliferation indices
were significantly higher in irradiated cells vis-à-vis their unirradiated
counterparts in each group studied, the increased proliferation rates
after UV irradiation were similar in WT and transgenic mice.
Skin Carcinogenesis Experiments
Single furin transgenic mice. To investigate the role of furin during
UV carcinogenesis, we treated WT and transgenic animals with twice
Figure 6. UV carcinogenesis experiments with single transgenic mice: Panel A depicts the tumor multiplicity as expressed by SCC/
mouse during the course of the experiment as counted once weekly and determined by the presence of large (>10 mm) infiltrating
or ulcerated lesions of the dorsal skin. Panel B shows the number of SCC/mouse at the last time point (34 weeks) as determined by the
histopathologic evaluation of all tumors. Pie charts showing the distribution of SCCs of different histopathologic grades in WT SKH-1
mice (C), transgenic SF47 mice (D), and transgenic SF49 mice (E).
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weekly exposures to UVB. Skin papillomas and carcinomas developed
in both transgenic and WT groups at approximately 20 and 25 weeks,
respectively. No statistically different incidence and multiplicity of
papillomas were noted between WT and transgenic groups (data not
shown). The prevalence of SCCs was extremely low in all groups until
week 28, and it was in the last 6 weeks (week 28 to week 34) that the
number of SCC/mouse increased but remained rather similar at 34 weeks
in both transgenic lines and in WT mice (approximately two SSCs
per mouse as seen grossly; Figure 6A). Mice from line SF47 devel-
oped a slightly higher number of SCC/mouse than did WT mice
during the last few weeks of the experiment. However, histologic
assessment (Figure 6B ) showed that at 34 weeks the SCC multi-
plicity of SF47 (5.3 SCC/mouse versus the gross count of 2.3 seen
in Figure 6A) was higher than that of WT (3.1 SCC/mouse; P <
.002), whereas the increased carcinoma/mouse observed histologi-
cally in SF49 mice was not statistically significant. Analysis of the
histopathologic grade of the SCCs in the different animal lines
showed that in WT mice at 34 weeks the majority of SCC were of
low-grade tumors, i.e., SCC I was 91% (Figure 6, C–E) and the per-
centage of high-grade SCC (SCC II to SCC IV) was 9%. Conversely, in
the transgenic lines, there was an increase in the percentage of high-
grade SCCs, i.e., 15% in SF47 mice and 26% in SF49 mice. Although
there was a clear difference with respect to WT animals, only SF49
mice showed a statistically significant difference in percentage of
high-grade tumors (P < .02).
Double PACE4/furin transgenic mice. Both double transgenic
lines generated (SPF47 and SPF49) showed intense expression of
both PCs as detected by Western blot analysis (Figure 7A). To eval-
uate if the in vivo overexpression of both furin and PACE4 would be
more effective in increasing the susceptibility to UV carcinogenesis
than any of these PCs alone, we selected both double transgenic
SPF47 and SPF49 and compared them with WT SKH-1 and mono-
genic transgenic mice expressing PACE4 also on SKH-1 background
Figure 7. UV carcinogenesis experiments with double transgenic mice: Western blot of epidermal skin keratinocytes derived from single
and double transgenic mice (A). Pie charts showing the distribution of SCCs of different histopathologic grades in the mice groups used
to evaluate PACE4 and furin double transgenic mice. WT SKH-1 mice (B), single transgenic SPACE4 (C), double transgenic SPF47 (D),
and double transgenic SPF49 (E). Note the increase in the percentage of higher grade SCCs in the double transgenic line.
176 UV Carcinogenesis in Furin Transgenic Mice Fu et al. Neoplasia Vol. 15, No. 2, 2013
(SPACE4). Surprisingly, both the single transgenic SPACE4 and the
double transgenic mice were not significantly different from the WT
SKH-1 mice in their susceptibility to UV carcinogenesis, at least based
on number of tumors counted macroscopically during the experiment
(data not shown). In addition, the tumor multiplicity curve and its
values were also quite similar to those seen in Figure 6A, depicting
tumor multiplicity in single furin transgenic mice. Nevertheless, fol-
lowing histopathologic evaluation at 34 weeks, double transgenic
SPF47 mice showed higher percentage of high-grade histotypes than
WT and single transgenic mice (P < .02) (Figure 7, B–D, also compare
with the experiments with single furin transgenic mice depicted in Fig-
ure 6, C–E ). Although not statistically significant, similar trends were
observed in the SPF49 double transgenic mouse line (Figure 7E ).
It is worth mentioning that occasional metastases were observed in
lymph nodes and lungs. Because of the low numbers, it was not pos-
sible to establish any differences between the mouse groups.
Discussion
Furin is the most studied of all PCs and has been detected in numer-
ous experimental and spontaneous malignancies. Furin is frequently
overexpressed in several human cancers [32–34,38,41,54] and in
chemically induced murine skin tumor cells [44]. Its role in the devel-
opment and progression of neoplasia has been directly ascribed to its
processing activity that results in the activation of many cancer-related
proteins including important growth factors and receptors such
as IGF-1 and its receptor IGF-1R, transforming growth factor–β,
etc. [14,55–58].
In a previous report [43], we described two transgenic mouse lines in
which furin was targeted to the epidermis using the K5 promoter (F47
and F49). Using these two single transgenic lines, we showed that the
transgenic overexpression of furin is able to increase the susceptibility to
skin carcinogenesis when mice were treated with the classic two-stage
carcinogenesis protocol using 7,12-dimethylbenz(a)anthracene (DMBA)
as the initiator and the phorbol ester tetradecanoylphorbol acetate
(TPA) as the promoter [43]. Although chemical carcinogenesis of the
skin and especially the multistage protocols have been extensively used
as general models or paradigms of human epithelial carcinogenesis,
in particular those of lung and head and neck [59,60], it is obvious
that UV radiation is the most important etiological agent of human
skin cancers. Because of this immediate relevancy to human melanoma
and non-melanoma skin cancer, we backcrossed both lines to an SKH-1
background to be able to evaluate the effect of the epidermal over-
expression of furin on the susceptibility of UV skin carcinogenesis.
The furin transgene, now on an SKH-1 background (SF47 and
SF49), was expressed in the epidermis and also in several other squa-
mous epithelia as we previously showed in similar mice on an FVB
background. Interestingly, the difference in expression patterns be-
tween the two animal lines were different, i.e., in the FVB lines,
F47 expressed more furin than line F49. Backcrossing of these lines
to an SKH-1 background resulted in a relative increase of furin expres-
sion in line SF49 when compared to line SF47. IHC analysis of both
lines revealed increased number of basal keratinocytes expressing furin.
The enhanced furin expression in transgenic mice was reflected in
higher levels of activated IGF-1R as demonstrated by Western blot
analysis. Except for these differences from WT mice, the animals
showed no spontaneous gross phenotype and remained healthy for at
least 12 months.
The interesting observation that in human immortalized HaCaT
keratinocytes UV irradiation induces an immediate increase in furin
transcripts [45] was also noted to some extent in UV-irradiated trans-
genic keratinocytes derived from the SF47 mouse line. Nevertheless,
this increase was mild compared to the 10-fold increase described by
Skiba et al. [45]. Although this increment in furin transcripts in
SF47 keratinocytes was only two-fold with respect to unirradiated
keratinocytes (Figure 4), it does correlate with an increase in the
in vivo carcinogenicity expressed as an almost two-fold increase in the
tumor multiplicity of this mouse transgenic line (Figure 6B).
The main goal of this project was to demonstrate that the trans-
genic expression of furin in the epidermis would have an enhancing
effect on skin UV carcinogenesis. During the entire experimental
period after the appearance of benign tumors or papillomas, the
mean number of papillomas/mouse was similar in both transgenic
mouse lines and not significantly different from WT mice. Similarly,
the mean number of SCC/mouse at 34 weeks of treatment with the
UVB carcinogenesis protocol showed no major differences when the
SCCs were counted macroscopically in the live animals. In contrast,
when the tumors were verified by a detailed histopathologic analysis
at 34 weeks, we found that the transgenic lines exhibited a higher
incidence of SCCs than the control SKH-1 WT mice. This was
caused by the presence of smaller non-ulcerated tumors that were
judged clinically to be benign but at closer microscopical examina-
tion contained invasive cancers. Moreover, the percentage of well-
differentiated tumors (SCC I) dropped significantly from 91% in
the WT group to 85% in the SF47 mice and to 74% in the SF49
animals exposed to UVB. This corresponds to the significant increase
in higher grade SCCs (SCC II to SCC IV), i.e., from 9% in WT to
15% in SF47 and to 26% in SF49 mice.
We also analyzed double transgenic mice that resulted from cross-
ing either SF47 or SF49 mice expressing furin with the monogenic
mouse line expressing PACE4, SPACE4. To our surprise, the inci-
dence of SCCs in double transgenic mice was not different from any
of the single transgenic mouse lines subjected to the same UVB carcino-
genesis protocol. Nevertheless, single transgenic mice as well as the
double transgenic mice had a significantly larger number of high-grade
SCCs than the WT mice. Especially, the double transgenic SPF47 had
33% of SCC with grades higher than SCC I, whereas single transgenics
had between 15% and 26% of SCC II to SCC IV and the WT SKH-1
had only 9% and 11%. The other double transgenic mouse line
(SPF49) exposed to UV radiation did not show differences in tumor
incidence and multiplicity when compared to single transgenic mice.
The latter results may be explained by an in vivo superposition of func-
tions or redundancy between the two PCs involved in the experiments
with double transgenic mice. Several studies have evaluated or specu-
lated on the eventual overlap and/or redundancy of PCs as it relates to
their function and downstream effects. The development of knockout
mice have permitted the evaluation of PCs during embryogenesis, and
such studies have revealed that PCs may not be redundant in function
since many of them are totally or partially lethal, as, for example, the
furin (totally lethal) and PACE4 knockout mice (25% lethality) [61].
However, in adult organs, redundancy may be more common in some
specific tissues [61]. It is possible that, to a certain extent, this also
happens in our model of double transgenic mice.
The comparison of tumor data in single transgenic mice exposed
either to chemical carcinogens [43] or to UVB radiation showed that
furin transgenics are more susceptible to chemical carcinogenesis
than to UVB. This comparison may not be straightforward, because
mice of different backgrounds were used and only one standardized
schedule of administration and dosage protocol for each of these
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experiments was performed. Nevertheless, it is congruent with the
fact that in mice, depending on the strain used, UV is usually a weaker
carcinogen than the stronger chemical carcinogens used in our two-
stage carcinogenesis protocol [62,63].
In summary, furin expression targeted in vivo to the epidermis
resulted in an increased pro-proliferative cancer-related substrate
activation resulting in a pro-tumorigenic effect that was manifested
in an increased number of UVB-induced higher grade SCCs late
during the process of carcinogenesis. Moreover, the expected additive
or synergistic effect of the two ubiquitous PCs, furin and PACE4,
did not pan out as expected, i.e., double transgenics expressing furin
and PACE4 showed no increased tumor incidence or multiplicity
and only a moderately higher percentage of more aggressive (higher
grade) SCCs than their single transgenic counterparts.
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